Craneware plc
CRWRF
Other OTC16.20
USD
-8.00
- -
ISIN
GB00B2425G68
Return %
Stock
S&P500
1Y
-50.58
18.21
3Y
-19.00
63.29
5Y
-46.36
74.90
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Keith Neilson
- Full Time Employees
- 747
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- 1 Tanfield Edinburgh SC United Kingdom EH3 5DA
- IPO Date
- Feb 7, 2012
- Website
- craneware.com
- Similar Companies
- Business
- Craneware plc develops, licenses, and supports software solutions primarily for the US healthcare industry, specializing in automated revenue integrity, pricing, cost support, and 340B/pharmacy management. Its core product portfolio includes the Trisus cloud ecosystem, which integrates revenue intelligence, margin intelligence, decision support, and advanced analytics to enhance financial performance for hospitals and health systems. The company offers software licenses, professional services including installation, and white-labeled solutions to healthcare providers. Craneware's flagship offerings include the Trisus Chargemaster, which has received Microsoft's "AI for Healthcare" certification and industry accolades such as "Best in KLAS." Founded in 1999 and headquartered in Edinburgh, United Kingdom, Craneware operates primarily in the US market. It serves a broad customer base of healthcare organizations, including hospitals, regional health systems, and teaching systems. The company emphasizes deep healthcare expertise combined with engineering excellence, positioning itself as a strategic partner in healthcare financial performance and operational improvements. Recent major developments include the acquisition and integration of Sentry Data Systems and Agilum Healthcare, enhancing Craneware’s 340B management and revenue cycle offerings. In 2025, Craneware secured a new $100 million revolving credit facility with a consortium of major banks to support potential acquisitions and business growth initiatives. The company reported a 9% revenue increase to $205.7 million for the fiscal year ended June 2025, alongside strong profitability and a 10% rise in dividends. Craneware also confirmed strategic contract wins, including multi-year agreements expanding the use of its Trisus platform across new hospitals and contract pharmacies. The company is currently engaged in a potential acquisition offer assessment by Bain Capital Private Equity. Craneware’s products and strategic initiatives solidify its leadership in healthcare financial software solutions, supporting clients in navigating the complexities of healthcare finance through advanced technology and data-driven insights. The company's continuous investments in product development and acquisitions aim to expand its market position and enhance its service offerings in the evolving US healthcare landscape.
Craneware shares slump after slower conversion triggers profit warning
Craneware plc (CRWRF) Q2 2026 Earnings Call Prepared Remarks Transcript
Craneware (OTCMKTS:CRWRF) Trading Down 24.5% – What’s Next?